CRH and cancer: Of the 65 pathways identified for ICH [7] and the 25 for SAH-V (current study), five overlapped including alpha adrenergic signaling, renin–angiotensin signaling, phospholipase C, corticotropin-releasing hormone signaling, and cancer mechanisms.